Prognostic significance of circumferential resection margin involvement following oesophagectomy for cancer and the predictive role of endoluminal ultrasonography

British Journal of Cancer

Volumn 107, Issue 12, 2012, Pages 1925-1931

  Reid, T D ^a   Chan, D S Y ^a   Roberts, S A ^a   Crosby, T D L ^b   Williams, G T ^a   Lewis, W G ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b VELINDRE CANCER CENTRE   (United Kingdom)

Author keywords

circumferential resection margin; neoadjuvant chemoradiotherapy; neoadjuvant chemotherapy; oesophageal cancer; oesophagectomy

Indexed keywords

CISPLATIN; EPIRUBICIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHEMORADIOTHERAPY; CIRCUMFERENTIAL RESECTION MARGIN; DISEASE FREE SURVIVAL; DISEASE SEVERITY; ENDOLUMINAL ULTRASONOGRAPHY; ENDOSCOPIC ECHOGRAPHY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; MORBIDITY; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; SURGICAL MORTALITY; SURGICAL PATIENT; SURVIVAL TIME;

ADULT; AGED; ANALYSIS OF VARIANCE; CHEMORADIOTHERAPY, ADJUVANT; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; ENDOSONOGRAPHY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOSCOPY; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 84870836380     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.511     Document Type: Article

References (37)

1. Adam IJ, Mohamdee MO, Martin IG, Scott N, Finan PJ, Johnston D,Dixon MF, Quirke P (1994) Role of circumferential margininvolvement in the local recurrence of rectal cancer. Lancet 344(8924):707-711
2. Allum WH, Stenning SP, Bancewicz J, Clark PI, Langley RE (2009) Longtermresults of a randomized trial of surgery with and withoutpreoperative chemotherapy in esophageal cancer. J Clin Oncol 27(30):5062-5067
3. Burmeister B, Thomas JM, Burmeister EA, Walpole ET, Harvey JA,Thomson DB, Barbour AP, Gotley DC, Smithers BM (2011) Is concurrentradiation therapy required in patients receiving preoperative chemotherapyfor adenocarcinoma of the oesophagus? A randomised phase II trial.Eur J Cancer 47(3): 354-360
4. Chao YK, Yeh CJ, Chang HK, Tseng CK, Chu YY, Hsieh MJ, Wu YC, Liu HP(2011) Impact of circumferential resection margin distance on locoregionalrecurrence and survival after chemopradiotherapy in esophagealsquamous cell carcinoma. Ann Surg Oncol 18(2): 529-534
5. Deeter M, Dover R, Kuppusamy MK, Koehler RP, Low DE (2009)Assessment of criteria and clinical significance of circumferentialresection margins in esophageal cancer. Arch Surg 144(7): 618-624
6. Dexter SP, Sue-Ling H, McMahonMJ, Quirke P,Mapstone N, Martin IG (2001)Circumferential resection margin involvement; an independent predictor ofsurvival following surgery for oesophageal cancer. Gut 48(5): 667-670
7. Griffiths EA, Brummell Z, Gorthi G, Pritchard SA, Welch IM (2006) Theprognostic value of circumferential resection margin involvement inoesophageal malignancy. Eur J Surg Oncol 32(4): 413-419
8. Harvin JA, Lahat G, Correa AM, Lee J, Maru D, Ajani J, Marom EM, WelshJ, Bhutani MS, Walsh G, Roth J, Mehran R, Vaporciyan A, Rice D,Swisher S, Hofsetter W (2012) Neoadjuvant chemoradiotherapy followedby surgery for esophageal adenocarcinoma: significance of microscopicallypositive circumferential radial margins. J Thorac Cardiovasc Surg143(2): 412-420
9. Hingorani M, Crosby T, Maraveyas A, Dixit S, Bateman A, Roy R (2011)Neoadjuvant chemoradiotherapy for resectable oesophageal and gastrooesophagealjunction cancer-do we need another randomised trial? ClinOncol 23(10): 696-705
10. Khan OA, Fitzgerald JJ, Soomro I, Beggs FD, Morgan WE, Duffy JP (2003)Prognostic significance of circumferential margin resection margininvolvement following oesophagectomy for cancer. Br J Cancer 88(10):1549-1552
11. Klautke G, Feyerherd P, Ludwig K, Prall F, Foitzik T, Fietkau R (2005)Intensified concurrent chemoradiotherapy with 5-fluorouracil andirinotecan as neoadjuvant treatment in patients with locally advancedrectal cancer. Br J Cancer 92(7): 1215-1220
12. Lahaye MJ, Engelen SM, Nelemans PJ, Beets GL, van de Velde CJ,van Engelshoven JM, Beets-tan RG (2005) Imaging for predicting the riskfactors-the circumferential resection margin and nodal disease-of localrecurrence in rectal cancer: a meta-analysis. Semin Ultrasound CT MR26(4): 259-268
13. Mapstone NP. Dataset for the Histopathological Reporting of OesophagealCarcinoma. Royal College of Pathologists: London (1998)
14. Mapstone NP. Dataset for the Histopathological Reporting of OesophagealCarcinoma. 2nd edn. Royal College of Pathologists: London (2007)
15. Mariette C, Piessen G, Briez N, Triboulet JP (2008) The number ofmetastatic lymph nodes and the ratio between metastatic and examinedlymph nodes are independent prognostic factors in esophageal cancerregardless of neoadjuvant chemoradiation or lymphadenectomy extent.Ann Surg 247(2): 365-371
16. Medical Research Council Oesophageal Cancer Working Group (2002)Surgical resection with or without preoperative chemotherapy inoesophageal cancer; a randomised controlled trial. Lancet 359(9319):1727-1733
17. Mirnezami R, Rohatgi A, Sutcliffe RP, Hamouda A, Chandrakumaran K,Botha A, Mason RC (2010) Multivariate analysis of clinicopathologicalfactors influencing survival following esophagectomy for cancer.Int J Surg 8(1): 53-63
18. Morgan MA, Lewis WG, Crosby TDL, Escofet X, Roberts SA, Brewster AE,Harvard TJ, Clark GW (2007) Prospective cohort comparison ofneoadjuvant chemoradiotherapy versus chemotherapy for patientsdiagnosed with oesophageal cancer. Br J Surg 94(12): 1509-1514
19. NHS Information Centre (2010) National Oesophago-Gastric Cancer Audit2010. http://www.ic.nhs.uk/ogreports (accessed 01 May 2012)
20. Pultrum BB, Honing J, Smit JK, van Dulleman HM, van Dam GM, Groen H,Hollema H, Plukker JT (2010) A critical appraisal of circumferentialresection margins in esophageal carcinoma. Ann Surg Oncol 17(3):812-820
21. Rao VS, Yeung MM, Cooke J, Salim E, Jain PK (2012) Comparisonof circumferential resection margin clearance criteria with survivalafter surgery for cancer of the esophagus. J Surg Oncol 105(8745-749
22. Reynolds JV, Muldoon C, Hollywood D, Ravi N, Rowley S, O'Byrne K,Kennedy J, Murphy TJ (2007) Long-term outcomes following neoadjuvantchemoradiotherapy for esophageal cancer. Ann Surg 245(5):707-716
23. Riddell AM, Hillier J, Brown G, King DM, Wotherspoon AC, Thompson JN,Cunningham D, Allum WH (2006) Potential of surface-coil MRI forstaging of esophageal cancer. AJR Am J Roentgenol 187(5): 1280-1287
24. Sagar PM, Johnston D, McMahon MJ, Dixon MF, Quirke P (1993)Significance of circumferential resection margin involvement afteroesophagectomy for cancer. Br J Surg 80(11): 1386-1388
25. Saha AK, Sutton C, Rotimi O, Dexter S, Sue-Link H, Sarela AJ (2009)Neoadjuvant chemotherapy and surgery for esophogeal adenocarcinoma: prognostic value of circumferential resection margin and stratification ofN1 category. Ann Surg Oncol 16(5): 1364-1370
26. Scheepers JJG, van der Peet DL, Veenhof AA, Cuesta MA (2009) Influenceof circumferential resetion margin on prognosis in distal esophageal andgastroesophageal cancer approached through the transhiatal route. DisEsophagus 22(1): 42-48
27. Salih T, Jose P, Mehta SP, Mirza A, Udall G, Pritchard SA, Hayden JD,Grabsch HI (2012) Prognostic significance of cancer within 1 mm of thecircumferential resection margin in oesophageal cancer patients followingneo-adjuvant chemotherapy. Eur J Cardiothorac Surg; e-pub ahead ofprint 4 June 2012; doi:10.1093/ejcts/ezs331
28. Sjoquist KM, Burmeister BH, Smithers BM, Zalcberg JR, Simes RJ, BarbourA, Gebski V (2011) Survival after neoadjuvant chemotherapy orchemoradiotherapy for resectable oesophageal carcinoma: an updatedmeta-analysis. Lancet Oncol 12(7): 681-692
29. Stahl M, Walz MK, Stuschke M, Lehmann N, Meyer HJ, Riera-Knorrenschild J, Langer P, Engenhart-Cabillic R, Bitzer M, KonigsrainerA, Buddach W, Wilke H (2009) Phase III Comparison of preoperativechemotherapy compared with chemoradiotherapy in patients withlocally advanced adenocarcinoma of the esophagogastric junction.J Clin Oncol 27(6): 851-856
30. Sujendran V, Wheeler J, Baron R, Warren BF, Maynard N (2008) Effect ofneoadjuvant chemotherapy on circumferential margin positivity andits impact on prognosis in patients with resectable oesophageal cancer.Br J Surg 95(2): 191-194
31. Thompson SK, Ruszkiewicz AR, Jamieson GG, Esterman A, Watson DI,Wijnhoven BP, Lamb PJ, Devitt PG (2008) Improving the accuracy ofTNM staging in esophageal cancer: a pathological review of resectedspecimens. Ann Surg Oncol 15(12): 3447-3458
32. Urschel JD, Vasan H (2003) A meta-analysis of randomized controlled trialsthat compared neoadjuvant chemoradiation and surgery to surgery alonefor resectable esophageal cancer. Am J Surg 185(6): 538-543
33. van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van BergeHenegouwen MI, Wijnhoven BP, Richel DJ, Nieuwenhuijzen GA,Hospers GA, Bonenkamp JJ, Cuesta MA, Biaisse RJ, Busch OR, ten KateFJ, Creemers GJ, Punt CJ, Plukker JT, Verheul HM, Spillenaar Bilgen EJ,van Dekken J, van der Sangen MJ, Rozema T, Biermann K, Beukema JC,Piet AH, van Rij CM, Reinders JG, Tilanus HW, van der Gaast A, CROSSGroup (2012) Preoperative chemoradiotherapy for esophageal orjunctional cancer. N Engl J Med 366(22): 2074-2084
34. Verhage RJ, Zandvoort HJ, ten Kate FJ, van Hillegersberg R (2011) How todefine a positive circumferential resection margin in T3 adenocarcinomaof the esophagus. Am J Surg Pathol 35(6): 919-926
35. Von Rahden BH, Stein HJ, Feith M, Becker K, Siewert JR (2005) Lymphaticvessel invasion as a prognostic factor in patients with primary resectedadenocarcinoms of the esophagogastric junction. J Clin Oncol 23(4): 874-879
36. Washington K, Berlin J, Branton P, Burgart LJ, Carter DK, Fitzgibbons P,Frankel WL, Jessup J, Kakar S, Minsky B, Nakhleh R, Compton CC (2009)Protocol for the Examination of Specimens From Patients WithCarcinoma of the Esophagus. College of American Pathologists. http://www.cap.org/apps/docs/committees/ cancer/cancer-protocols/2009/Esophagus-09protocol.pdf (accessed 1 May 2012)
37. Weaver S, Blackshaw G, Lewis WG, Edwards P, Roberts SA, Thomas GV(2004) Comparison of special interest computerised tomography,endosonography and histopathological stage of oesophageal cancer. ClinRadiol 59(6): 499-504